Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PXD-101 enters phase I trial in hematologic cancer

July 2, 2004

Erbitux receives E.U. approval for metastatic colorectal cancer

July 2, 2004

Femara sNDA granted priority review by FDA

July 2, 2004

New IGF-1R inhibitors with potential in cancer therapy

July 2, 2004

Novel topoisomerase inhibitors identified by researchers at State U. of New Jersey

July 2, 2004

Retinoic metabolism inhibitors promising against prostate cancer

July 2, 2004

Exelixis submits IND for XL-999

July 2, 2004

FDA accepts IND for MN-029

July 2, 2004

Aplidin receives orphan drug status for ALL

July 2, 2004

Alimta receives positive opinion in Europe

July 1, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...